156 related articles for article (PubMed ID: 28513990)
41. Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population.
Jara L; Dubois K; Gaete D; de Mayo T; Ratkevicius N; Bravo T; Margarit S; Blanco R; Gómez F; Waugh E; Peralta O; Reyes JM; Ibáñez G; González-Hormazábal P
Breast Cancer Res Treat; 2010 Aug; 122(3):813-22. PubMed ID: 20054644
[TBL] [Abstract][Full Text] [Related]
42. Next-generation sequencing in familial breast cancer patients from Lebanon.
Jalkh N; Chouery E; Haidar Z; Khater C; Atallah D; Ali H; Marafie MJ; Al-Mulla MR; Al-Mulla F; Megarbane A
BMC Med Genomics; 2017 Feb; 10(1):8. PubMed ID: 28202063
[TBL] [Abstract][Full Text] [Related]
43. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Weischer M; Bojesen SE; Ellervik C; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Oncol; 2008 Feb; 26(4):542-8. PubMed ID: 18172190
[TBL] [Abstract][Full Text] [Related]
44. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J
Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186
[TBL] [Abstract][Full Text] [Related]
45. Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Drooger J; Akdeniz D; Pignol JP; Koppert LB; McCool D; Seynaeve CM; Hooning MJ; Jager A
Breast Cancer Res Treat; 2015 Nov; 154(1):171-80. PubMed ID: 26467044
[TBL] [Abstract][Full Text] [Related]
46. BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer.
Sabatier R; Adélaïde J; Finetti P; Ferrari A; Huiart L; Sobol H; Chaffanet M; Birnbaum D; Bertucci F
Genes Chromosomes Cancer; 2010 Dec; 49(12):1143-51. PubMed ID: 20842729
[TBL] [Abstract][Full Text] [Related]
47. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.
Gutiérrez-Enríquez S; Ramón Y Cajal T; Alonso C; Corral A; Carrasco P; Cornet M; Sanz J; Ribas M; Baiget M; Diez O
Breast Cancer Res Treat; 2011 Jun; 127(3):611-22. PubMed ID: 20625817
[TBL] [Abstract][Full Text] [Related]
48. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
49. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
[TBL] [Abstract][Full Text] [Related]
50. Systematic identification of molecular links between core and candidate genes in breast cancer.
Arroyo R; Suñé G; Zanzoni A; Duran-Frigola M; Alcalde V; Stracker TH; Soler-López M; Aloy P
J Mol Biol; 2015 Mar; 427(6 Pt B):1436-1450. PubMed ID: 25640309
[TBL] [Abstract][Full Text] [Related]
51. Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population.
Wang S; Zhang Y; Chen M; Wang Y; Feng Y; Xu Z; Zhang D; Sun Y; Fu Z
Oncotarget; 2018 Jun; 9(42):26616-26624. PubMed ID: 29928473
[TBL] [Abstract][Full Text] [Related]
52. The clinical significance of CHEK1 in breast cancer: a high-throughput data analysis and immunohistochemical study.
Wu M; Pang JS; Sun Q; Huang Y; Hou JY; Chen G; Zeng JJ; Feng ZB
Int J Clin Exp Pathol; 2019; 12(1):1-20. PubMed ID: 31933717
[TBL] [Abstract][Full Text] [Related]
53. BC-TFdb: a database of transcription factor drivers in breast cancer.
Khan A; Khan T; Nasir SN; Ali SS; Suleman M; Rizwan M; Waseem M; Ali S; Zhao X; Wei DQ
Database (Oxford); 2021 Apr; 2021():. PubMed ID: 33882119
[TBL] [Abstract][Full Text] [Related]
54. Response to Comment on "DNA damage is a pervasive cause of sequencing errors, directly confounding variant identification".
Chen L; Liu P; Evans TC; Ettwiller LM
Science; 2018 Sep; 361(6409):. PubMed ID: 30262470
[TBL] [Abstract][Full Text] [Related]
55. SnapShot: TCGA-Analyzed Tumors.
Blum A; Wang P; Zenklusen JC
Cell; 2018 Apr; 173(2):530. PubMed ID: 29625059
[TBL] [Abstract][Full Text] [Related]
56. Elucidation of Novel Therapeutic Targets for Breast Cancer with
Jeong JH; Yun JW; Kim HY; Heo CY; Lee S
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33557149
[TBL] [Abstract][Full Text] [Related]
57. Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
Dougherty BA; Lai Z; Hodgson DR; Orr MCM; Hawryluk M; Sun J; Yelensky R; Spencer SK; Robertson JD; Ho TW; Fielding A; Ledermann JA; Barrett JC
Oncotarget; 2017 Jul; 8(27):43653-43661. PubMed ID: 28525389
[TBL] [Abstract][Full Text] [Related]
58. Germline Mutations in Triple-Negative Breast Cancer.
Hahnen E; Hauke J; Engel C; Neidhardt G; Rhiem K; Schmutzler RK
Breast Care (Basel); 2017 Mar; 12(1):15-19. PubMed ID: 28611536
[TBL] [Abstract][Full Text] [Related]
59. Evaluating the NCCN Clinical Criteria for Recommending
Cropper C; Woodson A; Arun B; Barcenas C; Litton J; Noblin S; Liu D; Park M; Daniels M
J Natl Compr Canc Netw; 2017 Jun; 15(6):797-803. PubMed ID: 28596260
[No Abstract] [Full Text] [Related]
60. A radiosensitivity gene signature and PD-L1 status predict clinical outcome of patients with invasive breast carcinoma in The Cancer Genome Atlas (TCGA) dataset.
Jang BS; Kim IA
Radiother Oncol; 2017 Sep; 124(3):403-410. PubMed ID: 28579282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
